Product Specifications
| Catalog Number | BIC-1783E |
|---|---|
| Target | Bone morphogenetic protein 2 |
| Target Symbol | BMP2 |
| Species | Human |
| Expression System | E.coli |
| Expression Region | Gln283-Arg396 |
| Molecular Weight | 12.9 kDa (monomer) |
| Purity | ≥95%, by SDS-PAGE (under reducing (R) & Non-reducing conditions, visualized by Coomassie staining). |
| Endotoxin | ≤100 EU/mg by the LAL method. |
| Formulation | Lyophilized |
| Buffer | Lyophilized from a 0.22 μm filtered solution containing 0.1 M Acetic acid, 5% Trehalose, pH3.0. |
| Reconstitution | It is recommended to redissolve in 4 mM HCl. |
| Storage & Stability | 36 months at -20°C to -80°C in lyophilized state; 6 months at -20°C to -80°C under sterile conditions after reconstitution; 7-10 days at 2°C to 8°C under sterile conditions after reconstitution; Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipping | The product is shipped with blue ice. |
| Lead Time | Products are in stock, but custom products may require further consultation. |
| Accession | P12643 |
Bioactivity
Measured by its ability to induce alkaline phosphatase production by ATDC-5 cells. The expected ED50 for this effect is ＜0.5 μg/mL.
Quality Data
Recombinant Human BMP-2 (Cat. No. BIC-1783E) SDS-PAGE under reducing (R) & Non-reducing condition.
Highly consistent bioactivity between different production batches of Recombinant Human BMP-2 (Cat. No. BIC-1783E).
